Active vaccination with Dickkopf-1 induces protective and therapeutic antitumor immunity in murine multiple myeloma.
about
Modulating Dickkopf-1: A Strategy to Monitor or Treat Cancer?Immunogenic targets for specific immunotherapy in multiple myelomaKremen1 and Dickkopf1 control cell survival in a Wnt-independent mannerNovel therapeutic targets in myeloma bone disease.Dickkopf-1 is a key regulator of myeloma bone disease: opportunities and challenges for therapeutic interventionLenalidomide enhances the protective effect of a therapeutic vaccine and reverses immune suppression in mice bearing established lymphomas.Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma.Wnt signaling in bone formation and its therapeutic potential for bone diseases.Genetic Immunization With In Vivo Dendritic Cell-targeting Liposomal DNA Vaccine Carrier Induces Long-lasting Antitumor Immune Response.Gene-expression and in vitro function of mesenchymal stromal cells are affected in juvenile myelomonocytic leukemiaConcise review: Current concepts in bone marrow microenvironmental regulation of hematopoietic stem and progenitor cellsMonoclonal antibodies: potential new therapeutic treatment against multiple myeloma.Wnt signaling in leukemias and myeloma: T-cell factors are in control.Peptide vaccines for hematological malignancies: a missed promise?Dysregulated expression of dickkopfs for potential detection of hepatocellular carcinoma.T cell-based targeted immunotherapies for patients with multiple myeloma.OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal.Emerging treatment approaches for myeloma-related bone disease.Drug discovery and therapeutic delivery for the treatment of B and T cell tumors.Combined detection of dickkopf-1 subtype classification autoantibodies as biomarkers for the diagnosis and prognosis of non-small cell lung cancer.DKK1 as a novel target for myeloma immunotherapy.Oral administration of soluble β-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice.Pathogenesis of bone disease in multiple myeloma: from bench to bedside.A novel multi-epitope vaccine from MMSA-1 and DKK1 for multiple myeloma immunotherapy.Human DKK1 and human HSP70 fusion DNA vaccine induces an effective anti-tumor efficacy in murine multiple myeloma.
P2860
Q26745556-68A7EDC4-C562-4CF0-99C8-CB0692137EBFQ26859007-11A2898A-A59F-416E-865D-0D30C98CCA4EQ28975609-CDEBEB02-741E-4E01-BF90-6B7BF7FAD9E5Q34025065-FA068A91-BB9E-4457-86F1-713BC48A2F09Q34049686-2FB1A6E5-1D99-45B0-90C5-9AA4D2D5701FQ36090011-0386CF27-BCB0-4AEC-8BBE-E746CFEE5B7CQ36260677-E0AA84C6-4BD0-4CF9-AB71-3D00664194B2Q36414426-B1BEF58A-9C9A-4124-8EBB-14101A46598AQ36638647-179902D4-2EAC-4113-9A42-71CADE37B1CDQ36756884-CA2081DA-B39D-44D9-8082-BB15F4B3D197Q36779719-0DE55D13-CAC3-4281-BE0C-9F2B886FFA78Q36875748-0A49A03C-ED8A-45DB-96DF-A1F8480E836AQ38090691-4C24DEB0-3B2E-4065-9932-2796062A69FCQ38155205-9C1216B7-D747-43A3-A8E9-078A30FBE12DQ38176546-9EDFC514-3897-40FB-B092-380B53A4390DQ38210247-3C8B862C-2E4E-491F-87E4-8383A8FAF40EQ38246639-AE16716B-B4FB-46CE-994B-03C7F65344FEQ38374889-9C826E8D-0519-4BA9-B5F0-34B61A46F7FCQ39090721-6AF47514-4E64-423D-A2D6-317B9756AC12Q39381251-85993D7A-634F-4E24-B234-427C636788B6Q41144323-5D82FF06-6E59-41E8-808F-A538BAFD04FBQ42156831-84629180-F8B3-42AC-B8C5-80D6C230145AQ45344940-AE64F441-5E3B-4A14-A787-6AE0C02BC13AQ47734632-D779D186-E790-44E4-BC66-5017AC0453EFQ47829053-71D4F51C-8439-43A4-ACE2-2BB2F30122F8Q48507398-60979A35-1728-4360-804C-22B69FE19C92
P2860
Active vaccination with Dickkopf-1 induces protective and therapeutic antitumor immunity in murine multiple myeloma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Active vaccination with Dickko ...... ty in murine multiple myeloma.
@ast
Active vaccination with Dickko ...... ty in murine multiple myeloma.
@en
type
label
Active vaccination with Dickko ...... ty in murine multiple myeloma.
@ast
Active vaccination with Dickko ...... ty in murine multiple myeloma.
@en
prefLabel
Active vaccination with Dickko ...... ty in murine multiple myeloma.
@ast
Active vaccination with Dickko ...... ty in murine multiple myeloma.
@en
P2093
P2860
P1433
P1476
Active vaccination with Dickko ...... ty in murine multiple myeloma.
@en
P2093
Chengyun Zheng
Jianfei Qian
Larry W Kwak
Lijuan Wang
P2860
P304
P356
10.1182/BLOOD-2011-07-368472
P407
P577
2011-11-02T00:00:00Z